Earlier this month the U.S. Food and Drug Administration approved a Canadian HIV vaccine for human trials. It's called SAV001, and it will be tested in three phases. The first phase will involve 30 HIV-positive patients, the second phase will test 600 HIV-negative patients, and the third phase will involve 6,000 HIV-negative volunteers. There is a risk for those involved on contracting the virus, but this is a huge step towards prevention of one of the worst diseases in history. As if you needed another reason to love Canada.
